Send feedback

SUN2 p.Ile531Val

c.1591A>G · rs149140279 · VCV1599831

Benign Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.2206 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00356%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Emery-Dreifuss muscular dystrophy

⚠ Built without this gene's context — gene constraint and dosage, protein structure, pathways, panels and related-variant links were not looked up for this page. why

Computational evidence

Protein change
AlphaMissense0.2206likely benign
REVEL0.157moderately benign-leaning
SaProtLLR -7.67tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not looked up on this page · why
Constraint at this position
ConservationphyloP 6.1GERP 2.4, phastCons 1
Regional constrainto/e 0.70unconstrained · MANE · 2,037 bp · p 3.5e-07 · regional, not allelic
Overall
CADD24.6PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00356% European (non-Finnish) · 42/1,180,004 alleles
Filtering AF 0.00267% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00236%
Overall 0.0169% 273/1,612,946 alleles · very rare exomes 242/1,460,742 · genomes 31/152,204 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.682% 147
Remaining individualsnot grpmax-eligible 0.0432% 2,314
European (non-Finnish)grpmax 0.00356% 28,095
Finnishnot grpmax-eligible 0.00159% 62,980
African / African-American 0.00133% 74,920

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SUN2
Protein
p.Ile531Val
Coding
c.1591A>G
MANE Select
NM_015374
dbSNP
rs149140279
Type
single nucleotide variant
Location
chr22:38739414 (GRCh38)
Full SUN2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Emery-Dreifuss muscular dystrophy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Emery-Dreifuss muscular dystrophy (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, X-linked recessive
Onset
Childhood
Prevalence
1-9 / 1 000 000 (Europe)

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/sun2-p-ile531val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown